Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pletaal SR (Cilostazol) for PAD Symptoms in COAD
NCT01711333Phase 4Completed
- Sponsor
- Otsuka Holdings
- Start
- Oct 2012
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cilostazol in Peripheral Arterial Disease (PAD), sponsored by Otsuka Holdings. Started Oct 2012; status: completed.
02
Drugs
cilostazol
03
Conditions
Peripheral Arterial Disease (PAD)
Beyond the preview
Go deeper on NCT01711333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01711333.